Surviving Sepsis Campaign Data Collection Tool Data Table/Export Identifiers. 1 P a g e

Size: px
Start display at page:

Download "Surviving Sepsis Campaign Data Collection Tool Data Table/Export Identifiers. 1 P a g e"

Transcription

1 Surviving Sepsis Campaign Data Collection Tool Data Table/Export Identifiers 1 P a g e

2 Table Documentation for C:\SepsisDB\V2007\SurvivingSepsis.a.accdb Table Purpose Key Field(s) Abx antibiotics ChartID, Antibiotic, Drug, DrugTime, SiteID ABxArchive antibiotics ChartID, Antibiotic, Drug, DrugTime, SiteID ABXLookup Apache ApacheArchive Chart ChartArchive ChartDefaults CodeBook Antibiotic ChartID ChartID ChartID ChartID SiteID TableName, FieldName, Code FTPClient Site Transmit Table and Field Listing 2 P a g e

3 Table Field Description Type Code Text Abx ChartID Antibiotic broad-spectrum antibiotic Text Drug date of antibiotic administration DrugTime time of antibiotic administration SiteID TxtOtherABx specify other antibiotic Text ABxArchive ChartID Antibiotic broad-spectrum antibiotic Text Drug date of antibiotic administration DrugTime time of antibiotic administration SiteID TxtOtherABx specify other antibiotic Text ABXLookup Antibiotic Text Apache ChartID SiteID Temp core temperature, C Single 3 P a g e

4 ArtPressure mean arterial pressure, mm Hg HR heart rate RR respiratory rate, nonventilated or ventilated OxygenA oxygenation, Fio2>=.05, using A- ado2 OxygenB oxygenation, Fio2<.05, using PAO2, mm hg ArtpH arterial ph Single Na serum Na, mmol/l K serum K, mmol/l Single Creat serum creatinine, mg/dl Single ARF acute renal failure 1 No HCT Hct % Single WBC in 1000's Single GCS glascow coma score 2 Yes CHS chronic health status 0 None of above 2 Elective postop w/immunocompromise or hx of 4 P a g e

5 organ insufficiency 5 Nonoperative or emergence postop with immunocompromise or organ insufficiency HCO serum HCO3, venous-mmol/l Single Apache1 apache--temp score Apache2 apache--aprterial pressure score Apache3 apache--heart rate score Apache4 apache--respiratory rate score Apache5 apache--oxygenation score Apache6 apache--arterial ph score Apache7 apache--serum Na score Apache8 apache--serum K score Apache9 apache--serum creatinine score Apache10 apache--hct score Apache11 apache--wbc score Apache12 apache--glascow coma score Apache13 apache--serum HCO3 score Apache14 apache--age score 5 P a g e

6 ApacheArchive ChartID SiteID Temp core temperature, C Single ArtPressure mean arterial pressure, mm Hg HR heart rate RR respiratory rate, nonventilated or ventilated OxygenA oxygenation, Fio2>=.05, using A- ado2 OxygenB oxygenation, Fio2<.05, using PAO2, mm hg ArtpH arterial ph Single Na serum Na, mmol/l K serum K, mmol/l Single Creat serum creatinine, mg/dl Single ARF acute renal failure HCT Hct % Single WBC in 1000's Single GCS glascow coma score 6 P a g e

7 CHS chronic health status HCO serum HCO3, venous-mmol/l Single Apache1 apache--temp score Apache2 apache--aprterial pressure score Apache3 apache--heart rate score Apache4 apache--respiratory rate score Apache5 apache--oxygenation score Apache6 apache--arterial ph score Apache7 apache--serum Na score Apache8 apache--serum K score Apache9 apache--serum creatinine score Apache10 apache--hct score Apache11 apache--wbc score Apache12 apache--glascow coma score Apache13 apache--serum HCO3 score Apache14 apache--age score Chart ChartID SiteID 7 P a g e

8 PatientID Sepsis Admit Patient identifier assigned at site, first and last initials, last 4 digits of MRN, date treated (MMDDYY) met criteria for severe sepsis or septic shock Admission characteristic, admitted to ICU from ED, other unit, or already in ICU with other diagnosis Text 1 Severe sepsis 2 Septic shock 1 From ED 2 From Other Unit 3 in ICU with other diagnosis Admit date of hospital admission AdmitTime time of hospital admission Present PresentTime DOB Age date of presentation with sepsis (Time 0) time of presentation with sepsis (Time 0) Calculated for presentation date, right truncated at 85 for export Gender 1 Female 8 P a g e

9 LactateDone serum lactate obtained after time of presentation 2 Male 0 No 1 Yes 99 Unknown Lactate serum lactate value Single LactateUnit serum lactate units 1 mmol/l 2 mg/dl Lactate LactateTime date of serum lactate obtained after time of presentation time of serum lactate obtained after time of presentation Abx broad-spectrum antibiotic received 0 No 1 Yes 88 Started previously 99 Unknown CultureDone blood culture done 0 No 1 Yes 88 Collected previously 9 P a g e

10 99 Unknown Culture CultureTime date of blood culture obtained after time of presentation time of blood culture obtained after time of presentation Hypo was patient hypotensive 0 No 1 Yes SBP90 if hypotensive, SBP<90 mm Hg 0 No 1 Yes 88 N/A MAP65 if hypotensive, MAP<65 mm Hg 0 No 1 Yes 88 N/A SBPDecrease Crystalloid if hypotensive, SBP decrease of >=40 mm Hg patient received >=30ml/kg crystalloid for hypotension or lactate>=4mmol/l (36 mg/dl) 0 No 1 Yes 88 N/A 0 No 10 P a g e

11 MAP65Fluid Pressors MAP65Pressors if hypotensive or lactate>=4mmol/l (36 mg/dl), MAP remained >=65 mmhg after initial fluid resuscitation if hypotensive after fluid challenge, did patient receive vasopressors? if hypotensive or lactate>=4mmol/l (36 mg/dl), MAP remained >=65 mmhg without the use of vasopressors 1 Yes 88 N/A 0 No 1 Yes 88 N/A 99 Unknown 0 No 1 Yes 88 N/A 99 Unknown 0 No 1 Yes 88 N/A 99 Unknown 11 P a g e

12 CVP8 CVP8 CVP8Time ScvO2 if hypotensive or lactate>=4mmol/l (36 mg/dl), was CVP>=8 mm hg obtained within 24 hours? date of CVP>=8 mm hg obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) time of CVP>=8 mm hg obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) if hypotensive or lactate>=4mmol/l (36 mg/dl), was ScvO2 70% obtained within 24 hours? 0 First >=8 mm hg after 24 hours 1 First >=8 mm hg within 24 hours 2 Not obtained 88 N/A 99 Unknown 0 First 70% after 24 hours 1 First 70% within 24 hours 2 Not obtained 88 N/A 99 Unknown 12 P a g e

13 ScvO2 ScvO2Time CVPMeasured CVPMeasured CVPMeasuredTime ScvO2Measured date of ScvO2 70% obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) time of ScvO2 70% obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) if hypotensive or lactate>=4mmol/l (36 mg/dl), was CVP measured within 24 hours? date of CVP>=8 mm Hg measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) time of CVP>=8 mm Hg measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) if hypotensive or lactate>=4mmol/l (36 mg/dl), was ScvO2 measured 0 First CVP measured after 24 hours 1 First CVP measured within 24 hours 2 Not obtained 88 N/A 0 First ScvO2 measured after 24 hours 13 P a g e

14 within 24 hours? 1 First ScvO2 measured within 24 hours 2 Not obtained 88 N/A ScvO2Measured date of ScvO2 measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) ScvO2MeasuredTime time of ScvO2 measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) CL if persistent arterial hypotension or lactate >=4mmol/L (36 mg/dl), was a central line inserted after the time of presentation? CL date of central line insertion CLTime time of central line insertion DC date of hospital discharge DCTime time of hospital discharge Status status at hospital discharge 0 Deceased 14 P a g e

15 1 Alive 99 Unknown Record B3_1 B3_2 B3_3 B3_4 B3_All Mortality 3 Hr Bundle 1--serum lactate measure within 3 hours 3 Hr Bundle 2--blood cultures collected before broad spectrum antibiotic 3 Hr Bundle 3--broad spectrum antibiotic administered within 3 hours 3 Hr Bundle 4--fluid bolus if needed for hypotension or lactacte>=4mmhg within 3 hours 3 Hr Bundle 5--compliance with all applicable elements of 3 hr bundle All bundles--mortality due to severe sepsis or septic shock BM_1 6 Hr Bundle measured 1-- vasopressors if needed after fluid bolus failed to maintain MAP>=65mmHg within 6 hours 15 P a g e

16 BM_2 6 Hr Bundle measured 2--CVP measured if shock or lactate>=4 within 6 hours BM_3 6 Hr Bundle measured 3-- ScvO2/SvO2 measured if shock or lactate>=4 within 6 hours Remeasure 6 Hr Bundle measured 4--lactate remeasured if initial lactate>2 within 6 hours BM_All 6 Hr Bundle measured 5-- compliance with all elements of the measured 6 hour bundle BM_Both 6 Hr Bundle measured 6-- compliance with all applicable elements of the 3 hour bundle and achieved 6 hour bundle BA_1 6 Hr Bundle achieved 1-- vasopressors if needed after fluid bolus failed to maintain MAP>=65mmHg within 6 hours BA_2 6 Hr Bundle achieved 2--CVP >=8mmHg if shock or lactate>=4 within 6 hours BA_3 6 Hr Bundle achieved 3--ScvO2 70% or SvO2 65% achieved if shock or 16 P a g e

17 lactate>=4 within 6 hours BA_All 6 Hr Bundle achieved 5-- compliance with all applicable elements of the achieved 6 hourbundle BA_Both 6 Hr Bundle achieved 6-- compliance with all applicable elements of the 3 hour bundle and achieved 6 hour bundle QScore3 3 Hr Bundle--Total quality score QScoreM QScoreA QScoreApplicable QScoreUnique Pneumonia 6 Hr Bundle measured--total quality score 6 Hr Bundle achieved--total quality score number of unique indicators applicable to this patient number of unique indicators satisfied Screen 1: new infection-- pneumonia/empyema UTI Screen 1: new infection--uti Abdominal Screen 1: new infection--acute 17 P a g e

18 abdominal infection Meningitis Screen 1: new infection--meningitis Skin Bone Wound Catheter Endocarditis Device OtherInfection Hyperthermia Hypothermia Screen 1: new infection--skin/soft tissue inflammation Screen 1: new infection--bone/joint infectoin Screen 1: new infection--wound infection Screen 1: new infection--catheter infection Screen 1: new infection-- endocarditis Screen 1: new infection-device infection Screen 1: new infection--other infection Screen 2: sign or symptom of infection--hyperthermia>38.3 C (101.0 F) Screen 2: sign or symptom of infection--hypothermia<36 C (96.8 F) 18 P a g e

19 Chills Tachycardia Tachypnea Leukopenia Leukocytosis Hyperglycemia Mental Suspect SuspectTime Screen 2: sign or symptom of infection--chills with rigors-- DISCONTINUED ITEM JUNE 2013 Screen 2: sign or symptom of infection--tachycardia > 90 bpm Screen 2: sign or symptom of infection--tachypnea >20 bpm Screen 2: sign or symptom of infection--leukopenia (WBC count<4000 ul-1) Screen 2: sign or symptom of infection--leukocytosis (WBC count>12,000 ul-1) Screen 2: sign or symptom of infection--hyperglycemia (plasma glucose>140 mg/dl) in absence of diabetes Screen 2: remote organ dysfunction--acutely altered mental status date suspicion of infection is present time suspicion of infection is present 19 P a g e

20 ScreenSBP ScreenSBPDecrease SpO2 Creatinine Bilirubin Platelet Coagulopathy Screen 3: remote organ dysfunction--sbp<90 or MAP<65 Screen 3: remote organ dysfunction--spb decrease>40 mmhg from baseline Screen 3: remote organ dysfunction--acute lung injury with Pao2/Fio2 <200 in the presence of pneumonia as infection source--item CHANGED JUNE 2013 Screen 3: remote organ dysfunction--creatinine>2.0mg/dl ( mmol/l) or urine output<0.5 ml/kg/hour for 2 hours Screen 3: remote organ dysfunction--bilirubin> 2 mg/dl (34.2 mmol/l) Screen 3: remote organ dysfunction--platelet count<100,000 Screen 3: remote organ dysfunction--coagulopathy (INR>1.5 or aptt>60 secs) ScreenLactate Screen 3: remote organ 20 P a g e

21 Pulmonary dysfunction--lactate>2 mmol/l (18.0 mg/dl) Screen 3: remote organ dysfunction--acute lung injury with Pao2/Fio2 ratio <250 in the absence of pneumonia as infection source--item CHANGED JUNE 2013 ICUAdmit date of ICU admission ICUAdmitTime time of ICU admission ICUDC date of ICU discharge ICUDCTime time of ICU discharge ElevatedLactate lactate >=4 mmol/dl or 36 mg/dl CatheterType 1 Intermittent 2 Continuous 88 N/A AdmitET LactateET CultureET CVP8ET 21 P a g e

22 ScvO2ET CVPMeasuredET ScvO2MeasuredET DCET ICUAdmitET ICUDCET SuspectET Updated Completed Data entry complete Integer 0 Data entry incomplete 1 Yes 3 Data entry complete for 3 but not 6 hour bundles PatientID2 IndexChartID CCUAdmission NoGlucose PresentYear PresentMonth Text Integer 22 P a g e

23 Note CLET elapsed time between presentation and central line placement in minutes Text APACHE total APACHE II score RepeatLactate was lactate repeated within 6 hours of presentation (applies if initial lactate>2) 0 Lactate remeasured after 6 hours 1 Lactate remeasured within 6 hours 2 Not remeasured 88 N/A LowestLactate lowest lactate obtained within 6 hours of presentation Single RepeatLactate RepeatLactateTime RepeatLactateET date of first repeat lactate obtained within 6 hours of presentation time of first repeat lactate obtained within 6 hours of presentation elapsed time between presentation and first repeat lactate Crystalloid date of Crystalloid delivery CrystalloidTime time of Crystalloid delivery 23 P a g e

24 CrystalloidET elapsed time between presentation and Crystalloid delivery EDTriage date of ED triage EDTriageTime time of ED triage EDTriageET elapsed time between presentation and ED triage *ED triage changed to last sepsis screen -June 2013 ChartArchive ChartID SiteID PatientID Sepsis Admit Patient identifier assigned at site, first and last initials, last 4 digits of MRN, date treated (MMDDYY) met criteria for severe sepsis or septic shock Admission characteristic, admitted to ICU from ED, other unit, or already in ICU with other diagnosis Text Admit date of hospital admission AdmitTime time of hospital admission Present date of presentation with sepsis 24 P a g e

25 PresentTime DOB Age Gender LactateDone (Time 0) time of presentation with sepsis (Time 0) Calculated for presentation date, right truncated at 85 for export serum lactate obtained after time of presentation Lactate serum lactate value Single LactateUnit serum lactate units Lactate LactateTime date of serum lactate obtained after time of presentation time of serum lactate obtained after time of presentation Abx broad-spectrum antibiotic received CultureDone blood culture done Culture CultureTime date of blood culture obtained after time of presentation time of blood culture obtained after time of presentation 25 P a g e

26 Hypo was patient hypotensive SBP90 if hypotensive, SBP<90 mm hg MAP65 if hypotensive, MAP<65 mm hg SBPDecrease Crystalloid MAP65Fluid Pressors MAP65Pressors CVP8 CVP8 if hypotensive, SBP decrease of >=40 mm hg patient received >=30ml/kg crystalloid for hypotension or lactate >=4mmol/L (36 mg/dl) if hypotensive or lactate 4mmol/L (36 mg/dl), MAP remained >=65 after inital fluid resusitation if hypotensive, did patient received vasopressors? if hypotensive or lactate>=4mmol/l (36 mg/dl), MAP remained >=65 without the use of vasopressors if hypotensive or lactate>=4mmol/l (36 mg/dl), was CVP>=8 mm hg obtained within 24 hours? date of CVP>=8 mm hg obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) 26 P a g e

27 CVP8Time ScvO2 ScvO2 ScvO2Time CVPMeasured CVPMeasured CVPMeasuredTime time of CVP>=8 mm hg obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) if hypotensive or lactate>=4mmol/l (36 mg/dl), was ScvO2 70% obtained within 24 hours? date of ScvO2 70% obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) time of ScvO2 70% obtained within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) if hypotensive or lactate>=4mmol/l (36 mg/dl), was CVP measured within 24 hours? date of CVP>=8 mm hg measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) time of CVP>=8 mm hg measured within 24 hours after time of presentation if hypotensive or 27 P a g e

28 ScvO2Measured lactate>=4mmol/l (36 mg/dl) if hypotensive or lactate>=4mmol/l (36 mg/dl), was ScvO2 measured within 24 hours? ScvO2Measured date of ScvO2 measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) ScvO2MeasuredTime time of ScvO2 measured within 24 hours after time of presentation if hypotensive or lactate>=4mmol/l (36 mg/dl) CL if persistent arterial hypotension, was a central line inserted after the time of presentation? CL date of central line insertion CLTime time of central line insertion DC date of hospital discharge DCTime time of hospital discharge Status status at hospital discharge Record B3_1 3 Hr Bundle 1--serum lactate 28 P a g e

29 B3_2 B3_3 B3_4 B3_All Mortality measure within 3 hours 3 Hr Bundle 2--blood cultures collected before broad spectrum antibiotic 3 Hr Bundle 3--broad spectrum antibiotic administered within 3 hours 3 Hr Bundle 4--fluid bolus if needed for hypotension or lactacte>=4mmhg within 3 hours 3 Hr Bundle 5--compliance with all applicable elements of 3 hr bundle All bundles--mortality due to severe sepsis or septic shock BM_1 6 Hr Bundle measured 1-- vasopressors if needed after fluid bolus failed to maintain MAP>=65mmHg within 6 hours BM_2 6 Hr Bundle measured 2--CVP measured if shock or lactate>=4 within 6 hours BM_3 6 Hr Bundle measured 3-- ScvO2/SvO2 measured if shock or lactate>=4 within 6 hours 29 P a g e

30 Remeasure 6 Hr Bundle measured 4--lactate remeasured if lactate>=4 within 6 hours BM_All 6 Hr Bundle measured 5-- compliance with all elements of the measured septic shock bundle BM_Both 6 Hr Bundle measured 6-- compliance with all applicable elements of the 3 hour bundle and achieved septic shock bundle BA_1 6 Hr Bundle achieved 1-- vasopressors if needed after fluid bolus failed to maintain MAP>=65mmHg within 6 hours BA_2 6 Hr Bundle achieved 2--CVP >=8mmHg if shock or lactate>=4 within 6 hours BA_3 6 Hr Bundle achieved 3--ScvO2 70% or SvO2 65% achieved if shock or lactate>=4 within 6 hours BA_All 6 Hr Bundle achieved 5-- compliance with all applicable elements of the achieved 6 hour bundle 30 P a g e

31 BA_Both 6 Hr Bundle achieved 6-- compliance with all applicable elements of the 3 hour bundle and achieved 6 hour bundle QScore3 3 Hr Bundle--Total quality score QScoreM QScoreA QScoreApplicable QScoreUnique Pneumonia 6 Hr Bundle measured--total quality score 6 Hr Bundle achieved--total quality score number of unique indicators applicable to this patient number of unique indicators satisfied Screen 1: new infection-- pneumonia/empyema UTI Screen 1: new infection--uti Abdominal Screen 1: new infection--acute abdominal infection Meningitis Screen 1: new infection--meningitis Skin Screen 1: new infection--skin/soft tissue inflammation Bone Screen 1: new infection--bone/joint 31 P a g e

32 Wound Catheter Endocarditis Device OtherInfection Hyperthermia Hypothermia Chills Tachycardia infectoin Screen 1: new infection--wound infection Screen 1: new infection--catheter infection Screen 1: new infection-- endocarditis Screen 1: new infection-device infection Screen 1: new infection--other infection Screen 2: sign or symptom of infection--hyperthermia>38.3 C (101.0 F) Screen 2: sign or symptom of infection--hypothermia<36 C (96.8 F) Screen 2: sign or symptom of infection--chills with rigors DISCONTINUED ITEM JUNE 2013 Screen 2: sign or symptom of infection--tachycardia > 90 bpm 32 P a g e

33 Tachypnea Leukopenia Leukocytosis Hyperglycemia Mental Suspect SuspectTime ScreenSBP ScreenSBPDecrease Screen 2: sign or symptom of infection--tachypnea >20 bpm Screen 2: sign or symptom of infection--leukopenia (WBC count<4000 ul-1) Screen 2: sign or symptom of infection--leukocytosis (WBC count>12,000 ul-1) Screen 2: sign or symptom of infection--hyperglycemia (plasma glucose>140 mg/dl) in absence of diabetes Change from 120 to 140 June 2013 Screen 2: remote organ dysfunction--acutely altered mental status date suspicion of infection is present time suspicion of infection is present Screen 3: remote organ dysfunction--sbp<90 or MAP<65 Screen 3: remote organ dysfunction--spb decrease>40 33 P a g e

34 SpO2 Creatinine Bilirubin Platelet Coagulopathy ScreenLactate Pulmonary mmhg from baseline Screen 3: remote organ dysfunction --Acute lung injury with Pao2/Fio2 <200 in the presence of pneumonia as infection source--item CHANGED JUNE 2013 Screen 3: remote organ dysfunction--creatinine>2.0mg/dl ( mmol/l) or urine output<0.5 ml/kg/hour for 2 hours Screen 3: remote organ dysfunction--bilirubin> 2 mg/dl (34.2 mmol/l) Screen 3: remote organ dysfunction--platelet count<100,000 Screen 3: remote organ dysfunction--coagulopathy (INR>1.5 or aptt>60 secs) Screen 3: remote organ dysfunction--lactate>2 mmol/l (18.0 mg/dl) Screen 3: remote organ dysfunction-- Acute lung injury with 34 P a g e

35 Pao2/Fio2 ratio <250 in the absence of pneumonia as infection source --ITEM CHANGED JUNE 2013 ICUAdmit date of ICU admission ICUAdmitTime time of ICU admission ICUDC date of ICU discharge ICUDCTime time of ICU discharge ElevatedLactate lactate >=4 mmol/dl or 36 mg/dl CatheterType AdmitET LactateET CultureET CVP8ET ScvO2ET CVPMeasuredET ScvO2MeasuredET DCET ICUAdmitET ICUDCET 35 P a g e

36 SuspectET Updated Completed Data entry complete Integer PatientID2 IndexChartID CCUAdmission NoGlucose PresentYear PresentMonth Note CLET elapsed time between presentation and central line placement in minutes Text Integer Text APACHE total APACHE II score RepeatLactate was lactate repeated within 6 hours of presentation (applies if initial lactate>2) LowestLactate lowest lactate obtained within 6 hours of presentation Single RepeatLactate date of first repeat lactate obtained 36 P a g e

37 RepeatLactateTime RepeatLactateET within 6 hours of presentation time of first repeat lactate obtained within 6 hours of presentation elapsed time between presentation and first repeat lactate Crystalloid date of Crystalloid delivery CrystalloidTime time of Crystalloid delivery CrystalloidET elapsed time between presentation and Crystalloid delivery EDTriage date of ED triage EDTriageTime time of ED triage EDTriageET elapsed time between presentation and ED triage *ED triage changed to last sepsis screen -June 2013 ChartDefaults SiteID centrally assigned site id number Site locally assigned site name Text FirstName contact first name Text LastName contact last name Text Title contact title Text 37 P a g e

38 Street1 street address Text Street2 street address Text City State Country Zip CaseMix Text Text Text Text Text Academic site type Community site type University university affiliated Tertiary site type--tertiary care Quaternary site type-quaternary care Contact contact address Text IHI IHI registered address Text ICUClosed icu is managed by intensivists ICUOpen icu is managed by admitting specialty SICU surgical icu 38 P a g e

39 MICU medical icu NumVent number ventilated beds NumNonVent number nonventilated beds EDLink formal relationship exists with ED for care of septic patients UnivLink educational/university link TxtUnivLink describe educational/university link Text ReportOutcome part of national or regional outcomes reporting systems APII use AP II severity scoring SAPSII use SAPS II severity scoring OtherScore use other severity scoring txtotherscore describe other severity scoring Text LactateUnit CodeBook TableName Text FieldName Code Description Comment Text Text Text 39 P a g e

40 Default FTPClient FTPClient ftp client file location Text Site SiteID Transmit Transmit 40 P a g e

Core Measures SEPSIS UPDATES

Core Measures SEPSIS UPDATES Patricia Walker, RN-BC, BSN Evidence Based Practice Manager Quality Management Services UCLA Health System, Ronald Reagan Medical Center Core Measures SEPSIS UPDATES Sepsis Core Measures Bundle Requirements

More information

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013 Stony Brook Medicine Severe Sepsis/Septic Shock Recognition and Treatment Protocols Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August

More information

Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures

Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor No disclosures 1 2 3 Discuss data requirements -3 hour bundle -6 hour bundle Challenges and compliance issues Success 4 Based on the Surviving Sepsis

More information

SE5h, Sepsis Education.pdf. Surviving Sepsis

SE5h, Sepsis Education.pdf. Surviving Sepsis Surviving Sepsis 1 Scope and Impact of the Problem: Severe sepsis is a major healthcare problem that affects millions of people around the world each year with an extremely high mortality rate of 30 to

More information

Sepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status

Sepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status Patient exhibits two or more of the following SIRS criteria: Temperature greater than 38 o C (100.4 o F) or less SIRS than criteria 36 o C (96.8 o F) Heart Rate greater than 90 beats/minute Respiratory

More information

Decreasing Sepsis Mortality at the University of Colorado Hospital

Decreasing Sepsis Mortality at the University of Colorado Hospital Decreasing Sepsis Mortality at the University of Colorado Hospital Maureen Dzialo, RN, BSN - Nurse Manager, Cardiac Intensive Care Unit Olivia Kerveillant, RN Clinical Nurse III, Medical Intensive Care

More information

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting

More information

Sepsis: Identification and Treatment

Sepsis: Identification and Treatment Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge

More information

BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN

BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN R. Phillip Dellinger MD, MSc, MCCM Professor of Medicine Cooper Medical School of Rowan University Professor of Medicine University Medicine and Dentistry of

More information

John Gasman, MD Alec Jamieson, RN, MSN Kim Clifforth, RN, BSN, MSN, CNS Thomas T. Lam, MD. June 18, 2013

John Gasman, MD Alec Jamieson, RN, MSN Kim Clifforth, RN, BSN, MSN, CNS Thomas T. Lam, MD. June 18, 2013 John Gasman, MD Alec Jamieson, RN, MSN Kim Clifforth, RN, BSN, MSN, CNS Thomas T. Lam, MD June 18, 2013 Objectives Acquire knowledge on defining sepsis, severe sepsis and septic shock Recognize SIRS criteria.

More information

Inpatient Code Sepsis March Update. Sarah Prebil

Inpatient Code Sepsis March Update. Sarah Prebil Inpatient Code Sepsis March Update Sarah Prebil 3 hour bundle Time is life Kumar et al. Crit Care Med 2006; 34:1589-1596 But Sarah, why are you harassing us about sepsis? Pilot Results 10 Code Sepsis pabents

More information

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali

More information

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB

More information

Telemedicine Resuscitation & Arrest Trials (TreAT)

Telemedicine Resuscitation & Arrest Trials (TreAT) Telemedicine Resuscitation & Arrest Trials (TreAT) Telemedicine within the ED for treating Severe Sepsis: A Hub and Spoke Telemedicine pilot SUMR Intern: Karole Collier Mentor: Dr. Brendan Carr & Dr. Anish

More information

Clinical Study The Use of an Early Alert System to Improve Compliance with Sepsis Bundles and to Assess Impact on Mortality

Clinical Study The Use of an Early Alert System to Improve Compliance with Sepsis Bundles and to Assess Impact on Mortality Critical Care Research and Practice Volume 2012, Article ID 980369, 8 pages doi:10.1155/2012/980369 Clinical Study The Use of an Early Alert System to Improve Compliance with Sepsis Bundles and to Assess

More information

Recommendations: Other Supportive Therapy of Severe Sepsis*

Recommendations: Other Supportive Therapy of Severe Sepsis* Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial

More information

DRG 416 Septicemia. ICD-9-CM Coding Guidelines

DRG 416 Septicemia. ICD-9-CM Coding Guidelines oding uidelines Septicemia ICD-9-CM Coding Guidelines The below listed septicemia guidelines are not inclusive. The coder should refer to the applicable Coding Clinic guidelines for additional information.

More information

Common Ventilator Management Issues

Common Ventilator Management Issues Common Ventilator Management Issues William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center You have just admitted a 28 year-old

More information

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the

More information

It is recommended that the reader review each medical directive presented in this presentation along with the actual PCP Core medical directive.

It is recommended that the reader review each medical directive presented in this presentation along with the actual PCP Core medical directive. It is recommended that the reader review each medical directive presented in this presentation along with the actual PCP Core medical directive. This presentation will highlight the changes and any new

More information

Quiz 5 Heart Failure scores (n=163)

Quiz 5 Heart Failure scores (n=163) Quiz 5 Heart Failure summary statistics The correct answers to questions are indicated by *. Students were awarded 2 points for question #3 for either selecting spironolactone or eplerenone. However, the

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They

More information

Marilyn Grafstrom, MHA Sherrie Muhs, RN, BSN, CEN, Avera Health Tammy Hale, TriCounty Wadena

Marilyn Grafstrom, MHA Sherrie Muhs, RN, BSN, CEN, Avera Health Tammy Hale, TriCounty Wadena Marilyn Grafstrom, MHA Sherrie Muhs, RN, BSN, CEN, Avera Health Tammy Hale, TriCounty Wadena 1 CMS Partnership for Patients Leading Edge Advanced Practice Topics (LEAPT) MHA is 1 of only 6 Partnership

More information

A Protocol for Early Goal Directed Therapy in the Emergency Department: Can we change compliance?

A Protocol for Early Goal Directed Therapy in the Emergency Department: Can we change compliance? Luke Benvenuto CRC Rotation IRB Proposal A Protocol for Early Goal Directed Therapy in the Emergency Department: Can we change compliance? Study Purpose and Rationale The systemic inflammatory response

More information

+Severe Sepsis EMS Spearheads the Attack against a Devastating Syndrome

+Severe Sepsis EMS Spearheads the Attack against a Devastating Syndrome + +Severe Sepsis EMS Spearheads the Attack against a Devastating Syndrome By Andrew Garlisi MD MPH MBA VAQSF CASE PRESENTATION You are called to the residence of a 74 year-old female who has experienced

More information

Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data

Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Creating a Hybrid Database by Adding a POA Modifier and Numerical Laboratory Results to Administrative Claims Data Michael Pine, M.D., M.B.A. Michael Pine and Associates, Inc. mpine@consultmpa.com Overview

More information

Sepsis Management. National Clinical Guideline No. 6

Sepsis Management. National Clinical Guideline No. 6 Sepsis Management National Clinical Guideline No. 6 November 2014 Using this National Clinical Guideline The aim of the National Clinical Guideline is to facilitate the early recognition and appropriate

More information

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,

More information

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR: CLINICAL UNIT: ASSIGNMENT DATES: PATIENT (last initial):

More information

Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm

Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm CHAPTER 6 Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm JW Haveman, A Karliczek, ELG Verhoeven, IFJ Tielliu, R de Vos, JH Zwaveling, JJAM

More information

How To Review A Sepsis Case In Qmp Quality Management Portal

How To Review A Sepsis Case In Qmp Quality Management Portal Quality Management Portal (QMP) & Sepsis Data Analysis Lessons Learned & Progress To Date Nicole Falgout, RN Sepsis Coordinator Rei Cates Sr. Software Engineer UCLA Quality Management Services 1 Quality

More information

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor

More information

SEVERE SEPSIS/SEPTIC SHOCK. Erica C. DeBoer BSN, MA,CCRN-K, CNL

SEVERE SEPSIS/SEPTIC SHOCK. Erica C. DeBoer BSN, MA,CCRN-K, CNL SEVERE SEPSIS/SEPTIC SHOCK Erica C. DeBoer BSN, MA,CCRN-K, CNL OBJECTIVES Define severe sepsis and septic shock List core measure/early management steps for severe sepsis and septic shock Describe implementation

More information

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after

More information

Diabetic Ketoacidosis

Diabetic Ketoacidosis Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Diabetic Ketoacidosis Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should

More information

THERAPEUTIC INDUCED HYPOTHERMIA GUIDELINES

THERAPEUTIC INDUCED HYPOTHERMIA GUIDELINES THERAPEUTIC INDUCED HYPOTHERMIA GUIDELINES Guidelines for Inclusion: (check all that apply) Cardiac arrest patients with any of the following: Ventricular fibrillation Pulseless Ventricular tachycardia

More information

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:. The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES One Children s Plaza Dayton, OH 45404-1815 www.childrensdayton.org DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended

More information

KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE (GEN. ORG.) NURSING AFFAIRS. Scope of Service PEDIATRIC INTENSIVE CARE UNIT (PICU)

KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE (GEN. ORG.) NURSING AFFAIRS. Scope of Service PEDIATRIC INTENSIVE CARE UNIT (PICU) PICU-Jan.2012 Page 1 of 7 Number of Beds: 18 Nurse Patient Ratio: 1:1-2 : The Pediatric Intensive Care Unit (PICU) provides 24 hour intensive nursing care for patients aged neonate through adolescence.

More information

IMPAIRED BLOOD-GAS EXCHANGE. Intraoperative blood gas analysis

IMPAIRED BLOOD-GAS EXCHANGE. Intraoperative blood gas analysis IMPAIRED BLOOD-GAS EXCHANGE Intraoperative blood gas analysis When do you perform BGA Intraoperatively? Informe actual NEVER Routine:Thoracic Thoracic, Cardiac,Neurosurgery Emergency situation Drop in

More information

SEPSIS IN INFANTS AND CHILDREN- CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

SEPSIS IN INFANTS AND CHILDREN- CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline SEPSIS IN INFANTS AND CHILDREN- CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. This guideline is for the management of sepsis in Infants and children. For full guidance please see the Surviving

More information

Benjamin M. Marlin Department of Computer Science University of Massachusetts Amherst marlin@cs.umass.edu January 21, 2011

Benjamin M. Marlin Department of Computer Science University of Massachusetts Amherst marlin@cs.umass.edu January 21, 2011 Modeling and Prediction With ICU Electronic Health Records Data Department of Computer Science University of Massachusetts Amherst marlin@cs.umass.edu January 21, 2011 The Big Picture: History of Medical

More information

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes

More information

Michelle Pinelle RN, BSN, CCRN & Jamie Roney RN, BSN, CCRN Texas Tech University Health Sciences Center, Lubbock, Texas

Michelle Pinelle RN, BSN, CCRN & Jamie Roney RN, BSN, CCRN Texas Tech University Health Sciences Center, Lubbock, Texas Michelle Pinelle RN, BSN, CCRN & Jamie Roney RN, BSN, CCRN Texas Tech University Health Sciences Center, Lubbock, Texas AGREE II Tool Evaluation of Sepsis Guidelines 1. The learner will be able to discuss

More information

Severity scores in ICU

Severity scores in ICU Severity scores in ICU DM seminar Dr.Vamsi Krishna Mootha Dept of Pulmonary medicine, PGIMER Introduction Severity of illness scoring systems are developed to evaluate delivery of care and provide prediction

More information

Management of Sepsis in the Adult

Management of Sepsis in the Adult Management of Sepsis in the Adult Two (2.0) Contact Hours Course expires: 10/28/2017 First published: 10/28/ 2014 Reproduction and distribution of these materials is prohibited without an RN.com content

More information

CENTER FOR DRUG EVALUATION AND RESEARCH

CENTER FOR DRUG EVALUATION AND RESEARCH CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 205029Orig1s000 SUMMARY REVIEW Cross Discipline Team Leader Review 4. Nonclinical Pharmacology/Toxicology In their review of the original application,

More information

Adult CCRN/CCRN E/CCRN K Certification Review Course: Endocrine 12/2015. Endocrine 1. Disclosures. Nothing to disclose

Adult CCRN/CCRN E/CCRN K Certification Review Course: Endocrine 12/2015. Endocrine 1. Disclosures. Nothing to disclose Adult CCRN/CCRN E/CCRN K Certification Review Course: Carol Rauen RN BC, MS, PCCN, CCRN, CEN Disclosures Nothing to disclose 1 Body Harmony disorders and emergencies Body Harmony (cont) Introduction Disorders

More information

From AARC Protocol Committee; Subcommittee Adult Critical Care Version 1.0a (Sept., 2003), Subcommittee Chair, Susan P. Pilbeam

From AARC Protocol Committee; Subcommittee Adult Critical Care Version 1.0a (Sept., 2003), Subcommittee Chair, Susan P. Pilbeam AARC - ADULT MECHANICAL VENTILATOR PROTOCOLS 1. Guidelines for Using Ventilator Protocols 2. Definition of Modes and Suggestions for Use of Modes 3. Adult Respiratory Ventilator Protocol - Guidelines for

More information

Quality Scorecard overall heart attack care overall heart failure overall pneumonia care overall surgical infection rate patient safety survival

Quality Scorecard overall heart attack care overall heart failure overall pneumonia care overall surgical infection rate patient safety survival Quality Scorecard s are required to report quality statistics to the s for Medicare and Medicaid Services (CMS) and the Department of Health (DOH). This information is made available at www.hospitalcompare.hhs.gov

More information

Eliminating Pressure Ulcers in Ascension Health

Eliminating Pressure Ulcers in Ascension Health Eliminating Pressure Ulcers in Ascension Health Cissy Shanks RN BSN CEN & Pam Kleinhelter RN MSN CNA-BC Nursing Managers St Vincent s Health System Jacksonville, Florida Objectives Participants will be

More information

Medical Direction and Practices Board WHITE PAPER

Medical Direction and Practices Board WHITE PAPER Medical Direction and Practices Board WHITE PAPER Use of Pressors in Pre-Hospital Medicine: Proper Indication and State of the Science Regarding Proper Choice of Pressor BACKGROUND Shock is caused by a

More information

Hyperosmolar Non-Ketotic Diabetic State (HONK)

Hyperosmolar Non-Ketotic Diabetic State (HONK) Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis

More information

Understanding Lactate in an Intensive Care Setting. Hilary G. Mulholland

Understanding Lactate in an Intensive Care Setting. Hilary G. Mulholland Understanding Lactate in an Intensive Care Setting by Hilary G. Mulholland S.B., Massachusetts Institute of Technology (2014) Submitted to the Department of Electrical Engineering and Computer Science

More information

Severe Sepsis & Septic Shock Sepsis: the 1 st 6 hours. Objectives. What would you do? Case #2. What would you do? Case #1. What would you do?

Severe Sepsis & Septic Shock Sepsis: the 1 st 6 hours. Objectives. What would you do? Case #2. What would you do? Case #1. What would you do? Severe Sepsis Septic Shock Sepsis: the 1 st 6 hours Identification Initial Management Chris Fee, MD UCSF Division of Emergency Medicine 2007 Topics in Emergency Medicine Objectives Gain respect for severe

More information

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND Monitor patient on the ward to detect trends in vital signs and to manage accordingly To recognise deteriorating trends and request relevant medical/out

More information

Bedside Nutrition Monitoring Tool Instruction Manual. Intended Audience: ICU dietitians. Collaborative

Bedside Nutrition Monitoring Tool Instruction Manual. Intended Audience: ICU dietitians. Collaborative Bedside Nutrition Monitoring Tool Instruction Manual Intended Audience: ICU dietitians The Collaborative An exclusive opportunity for Intensive Care Units across Canada 0 Contents Contacts... 2 Glossary...

More information

Levels of Critical Care for Adult Patients

Levels of Critical Care for Adult Patients LEVELS OF CARE 1 Levels of Critical Care for Adult Patients STANDARDS AND GUIDELINES LEVELS OF CARE 2 Intensive Care Society 2009 All rights reserved. No reproduction, copy or transmission of this publication

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information

Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN

Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN Learning Outcomes Identify triggers to the IIR. Describe the pathophysiologic changes that

More information

Paediatric Advanced Warning Score (PAWS)

Paediatric Advanced Warning Score (PAWS) Paediatric Advanced Warning Score (PAWS) Prevention is better than cure. Spectrum of critical illness Ward level care HDU Care ICU Care Early admission may improve outcome ICU Outreach teams Medical Emergency

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Vasopressors. Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco

Vasopressors. Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco Vasopressors Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco Overview Define shock states Review drugs commonly used to treat hypotension

More information

Cardiac Arrest VF/Pulseless VT Learning Station Checklist

Cardiac Arrest VF/Pulseless VT Learning Station Checklist Cardiac Arrest VF/Pulseless VT Learning Station Checklist VF/VT 00 American Heart Association Adult Cardiac Arrest Shout for Help/Activate Emergency Response Epinephrine every - min Amiodarone Start CPR

More information

The Critically Ill Patient: Surgical Intensive Care. Dr. Thomas VanderLaan Dr. Melanie Walker Huntington Memorial Hospital Pasadena, California

The Critically Ill Patient: Surgical Intensive Care. Dr. Thomas VanderLaan Dr. Melanie Walker Huntington Memorial Hospital Pasadena, California The Critically Ill Patient: Surgical Intensive Care Dr. Thomas VanderLaan Dr. Melanie Walker Huntington Memorial Hospital Pasadena, California Outline Recognizing Critical Illness The Stress Response Systemic

More information

New Treatment Options in the Management of Sepsis

New Treatment Options in the Management of Sepsis New Treatment Options in the Management of Sepsis Henry J. Mann, Pharm.D., FCCM, FCCP, FASHP University of Minnesota College of Pharmacy- Department of Experimental and Clinical Pharmacology Center For

More information

Sepsis Awareness Month

Sepsis Awareness Month Aon Kenya Insurance Brokers Ltd Aon Hewitt Healthcare Division Sepsis Awareness Month Issue 11 September 2015 In this Issue 2 Getting to understand Sepsis 3 Stages in Sepsis Advancement 4 Diagnosis & Treatment

More information

Irish Wolfhound Pedigree Breed Health Survey

Irish Wolfhound Pedigree Breed Health Survey Irish Wolfhound Pedigree Breed Health Survey Forms were received representing 74 living dogs & 32 deceased dogs. Mortality results A total of 32 deaths were reported, representing 0.57% of all deaths reported

More information

Summary of EWS Policy for NHSP Staff

Summary of EWS Policy for NHSP Staff Summary of EWS Policy for NHSP Staff For full version see CMFT Intranet Contact Sister Donna Egan outreach coordinator bleep 8742 Tel: 0161 276 8742 Introduction The close monitoring of patients physiological

More information

MEDICAL INTENSIVE CARE UNIT - HEALTH SCIENCES CENTRE Reviewed August 2011

MEDICAL INTENSIVE CARE UNIT - HEALTH SCIENCES CENTRE Reviewed August 2011 MEDICAL INTENSIVE CARE UNIT - HEALTH SCIENCES CENTRE Reviewed August 2011 Goal The rotation in the Medical Intensive Care Unit at HSC is designed to allow the resident to encounter patients with tertiary

More information

SEPSIS. Promoting a better understanding of. Produced by the International Sepsis Forum

SEPSIS. Promoting a better understanding of. Produced by the International Sepsis Forum Second edition November 2003 Promoting a better understanding of SEPSIS Produced by the International Sepsis Forum The International Sepsis Forum is a volunteer organization dedicated to the advancement

More information

Acid-Base Balance and the Anion Gap

Acid-Base Balance and the Anion Gap Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very

More information

Person Centered Care: Walk the Talk

Person Centered Care: Walk the Talk Person Centered Care: Walk the Talk Integration of Nurse Practitioner (NP) Role into Extendicare Michener Hill Long Term Care (LTC) Presented by: Sandi Engi MN, NP Michener Hill Extendicare November 25

More information

Eileen Whitehead 2010 East Lancashire HC NHS Trust

Eileen Whitehead 2010 East Lancashire HC NHS Trust Eileen Whitehead 2010 East Lancashire HC NHS Trust 1 Introduction: Arterial blood gas analysis is an essential part of diagnosing and managing a patient s oxygenation status and acid-base balance However,

More information

Design and Implementation of a Real-Time Clinical Alerting System for Intensive Care Unit

Design and Implementation of a Real-Time Clinical Alerting System for Intensive Care Unit Design and Implementation of a Real-Time Clinical Alerting System for Intensive Care Unit Hsiao-Ting Chen 1, Wan-Chun Ma 2, Der-Ming Liou 1 1 Telemedicine Lab, Institute of Health Informatics and Decision

More information

CLINICAL DECISION-SUPPORT SYSTEMS (ALERTS), WHAT ARE THEY AND CAN THEY HELP MY PATIENT?

CLINICAL DECISION-SUPPORT SYSTEMS (ALERTS), WHAT ARE THEY AND CAN THEY HELP MY PATIENT? CLINICAL DECISION-SUPPORT SYSTEMS (ALERTS), WHAT ARE THEY AND CAN THEY HELP MY PATIENT? Robert Sherwin, MD Assistant Professor of Emergency Medicine Wayne State University School of Medicine Sinai Grace

More information

ANTIBIOTICS IN SEPSIS

ANTIBIOTICS IN SEPSIS ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics

More information

Severe Sepsis and Septic Shock: Review of the Literature and Emergency Department Management Guidelines

Severe Sepsis and Septic Shock: Review of the Literature and Emergency Department Management Guidelines INFECTIOUS DISEASE/REVIEW ARTICLE Severe Sepsis and Septic Shock: Review of the Literature and Emergency Department Management Guidelines H. Bryant Nguyen, MD, MS Emanuel P. Rivers, MD, MPH Fredrick M.

More information

Edwards FloTrac Sensor & Edwards Vigileo Monitor. Understanding Stroke Volume Variation and Its Clinical Application

Edwards FloTrac Sensor & Edwards Vigileo Monitor. Understanding Stroke Volume Variation and Its Clinical Application Edwards FloTrac Sensor & Edwards Vigileo Monitor Understanding Stroke Volume Variation and Its Clinical Application 1 Topics System Configuration Pulsus Paradoxes Reversed Pulsus Paradoxus What is Stroke

More information

Severe sepsis affects more than 20,000 children

Severe sepsis affects more than 20,000 children ORIGINAL RESEARCH CONTRIBUTION The Utility of Early Lactate Testing in Undifferentiated Pediatric Systemic Inflammatory Response Syndrome Halden F. Scott, MD, Aaron J. Donoghue, MD, MSCE, David F. Gaieski,

More information

Protocols for Early Extubation After Cardiothoracic Surgery

Protocols for Early Extubation After Cardiothoracic Surgery Protocols for Early Extubation After Cardiothoracic Surgery AATS / STS CT Critical Care Symposium April 27, 2014 Toronto, Ontario Nevin M. Katz, M.D. Johns Hopkins University Foundation for the Advancement

More information

Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014

Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014 Using Predictive Analytics to Improve Sepsis Outcomes 4/23/2014 Ryan Arnold, MD Department of Emergency Medicine and Value Institute Christiana Care Health System, Newark, DE Susan Niemeier, RN Chief Nursing

More information

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center Modified Early Warning Score (MEWS) Ruchika D. Husa, MD, MS Assistant t Professor of Medicine i in the Division of Cardiology The Ohio State University Wexner Medical Center MEWS Simple physiological scoring

More information

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs Vital Signs: Assessment and Interpretation Elma I. LeDoux, MD, FACP, FACC Associate Professor of Medicine Vtial sign #1: PULSE Reflects heart rate (resting 60-90/min) Should be strong and regular Use 2

More information

Implementation Guide

Implementation Guide HAWAII HEALTH INFORMATION CORPORATION HAWAII S SOURCE FOR HEALTHCARE Implementation Guide ASCII HL7 Specifications for Laboratory Observation Reporting Technical Specifications and Transmittal Instructions

More information

DISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE

DISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE REFERENCES: The Joint Commission Accreditation Manual for Hospitals American Society of Post Anesthesia Nurses: Standards of Post Anesthesia Nursing Practice (1991, 2002). RELATED DOCUMENTS: SHC Administrative

More information

Postoperative management in adults

Postoperative management in adults Scottish Intercollegiate Guidelines Net work 77 Postoperative management in adults A practical guide to postoperative care for clinical staff 1 Introduction 1 2 Clinical assessment and monitoring 3 3 Cardiovascular

More information

Southern California Patient Safety First Collaborative Long Beach Memorial Medical Center Team Presentation. September 17, 2014

Southern California Patient Safety First Collaborative Long Beach Memorial Medical Center Team Presentation. September 17, 2014 Southern California Patient Safety First Collaborative Long Beach Memorial Medical Center Team Presentation September 17, 2014 1907 2014 Not-for-profit, community-based One of few campuses home to adult

More information

VARIATION IN SEPSIS SYMPTOMS OF HOSPITAL PATIENTS ADMITTED FROM DIFFERENT POINTS OF ORIGIN TIMOTHY Y. LEE THESIS

VARIATION IN SEPSIS SYMPTOMS OF HOSPITAL PATIENTS ADMITTED FROM DIFFERENT POINTS OF ORIGIN TIMOTHY Y. LEE THESIS VARIATION IN SEPSIS SYMPTOMS OF HOSPITAL PATIENTS ADMITTED FROM DIFFERENT POINTS OF ORIGIN BY TIMOTHY Y. LEE THESIS Submitted in partial fulfillment of the requirements for the degree of Master of Science

More information

Chapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock

Chapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock Chapter 16 Shock Learning Objectives Explain difference between compensated and uncompensated shock Differentiate among 5 causes and types of shock: Hypovolemic Cardiogenic Neurogenic Septic Anaphylactic

More information

International Guidelines for Management of Severe Sepsis and Septic Shock

International Guidelines for Management of Severe Sepsis and Septic Shock International Guidelines for Management of Severe Sepsis and Septic Shock Sponsoring organizations: American Association of Critical-Care Nurses American College of Chest Physicians American College of

More information

THE AIRWAY IN AEROMEDICAL EVACUATION. PBLD (Problem Based Learning Discussion)

THE AIRWAY IN AEROMEDICAL EVACUATION. PBLD (Problem Based Learning Discussion) THE AIRWAY IN AEROMEDICAL EVACUATION PBLD (Problem Based Learning Discussion) D. John Doyle MD PhD 2012 Edition Image Credit: http://www.arabianaerospace.aero/media/images/stories/medevac%20services.jpg

More information

Adam J. Singer, MD, Merry Taylor, RN, Anna Domingo, Saad Ghazipura, Adam Khorasonchi, Henry C. Thode, Jr., PhD, and Nathan I.

Adam J. Singer, MD, Merry Taylor, RN, Anna Domingo, Saad Ghazipura, Adam Khorasonchi, Henry C. Thode, Jr., PhD, and Nathan I. ORIGINAL CONTRIBUTION Diagnostic Characteristics of a Clinical Screening Tool in Combination With Measuring Bedside Lactate Level in Emergency Department Patients With Suspected Sepsis Adam J. Singer,

More information

ACID- BASE and ELECTROLYTE BALANCE. MGHS School of EMT-Paramedic Program 2011

ACID- BASE and ELECTROLYTE BALANCE. MGHS School of EMT-Paramedic Program 2011 ACID- BASE and ELECTROLYTE BALANCE MGHS School of EMT-Paramedic Program 2011 ACID- BASE BALANCE Ions balance themselves like a see-saw. Solutions turn into acids when concentration of hydrogen ions rises

More information

Diabetic Emergencies. David Hill, D.O.

Diabetic Emergencies. David Hill, D.O. Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment

More information

Evidence-Based Management of Severe Sepsis and Septic Shock

Evidence-Based Management of Severe Sepsis and Septic Shock Evidence-Based Management of Severe Sepsis and Septic Shock JOSEPH M. KONTRA, M.D. Infection Specialists of Lancaster ABSTRACT Sepsis remains a frequent and deadly diagnosis in hospitals across the United

More information

Sue Carol Verrillo, RN, MSN, CRRN The Johns Hopkins Hospital November 14, 2014

Sue Carol Verrillo, RN, MSN, CRRN The Johns Hopkins Hospital November 14, 2014 Early Detection of Patient Deterioration Using Remote Patient Monitoring with Wireless Nurse Notification Sue Carol Verrillo, RN, MSN, CRRN The Johns Hopkins Hospital November 14, 2014 1 Why Remote Patient

More information

240- PROBLEM SET INSERTION OF SWAN-GANZ SYSTEMIC VASCULAR RESISTANCE. Blood pressure = f(cardiac output and peripheral resistance)

240- PROBLEM SET INSERTION OF SWAN-GANZ SYSTEMIC VASCULAR RESISTANCE. Blood pressure = f(cardiac output and peripheral resistance) 240- PROBLEM SET INSERTION OF SWAN-GANZ 50 kg Pig Rt Jugular 0 cm Rt Atrium 10 cm Rt ventricle 15 cm Wedge 20-25 cm SYSTEMIC VASCULAR RESISTANCE Blood pressure = f(cardiac output and peripheral resistance)

More information

INTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline

INTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline Acknowledgements Background Well child with normal hydration Unwell children (+/- abnormal hydration Maintenance Deficit Ongoing losses (e.g. from drains) Which fluid? Monitoring Special Fluids Post-operative

More information

Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes

Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Nursing home patients with diabetes treated with insulin and certain oral diabetes medications (i.e. sulfonylureas and glitinides) are

More information